Leimax, Corp. – FDA Warning Letter, Apr 19, 2022
On April 5-19, 2022, the FDA conducted an inspection of Leimax, Corp. at 179 Saw Mill River Rd #B, Yonkers, NY 10701, to assess compliance with the Foreign Supplier Verification Program (FSVP) regulation (21 CFR part 1, subpart L) under section 805 of the FD&C Act. Previous inspections occurred on June 18, 2018, and March 4, 2020.
The inspection revealed a significant violation: Leimax, Corp. failed to develop, maintain, and follow an FSVP for any imported foods, as required by 21 CFR 1.502(a). This non-compliance also violates section 805 of the FD&C Act. A Form FDA 483a FSVP Observations was issued on April 19, 2022, to which no response has been received.
If Leimax, Corp. qualifies as a "very small importer" under 21 CFR 1.500 and chooses to comply with modified requirements in 21 CFR 1.512, it must document this status (21 CFR 1.512(b)(1)(i)). Even as a very small importer, compliance with 21 CFR 1.502, 1.5
ID · 834667b8-99f3-447b-9e3a-097c5583614d
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.